ES2095578T3 - Composicion para el tratamiento de mastitis y metritis. - Google Patents

Composicion para el tratamiento de mastitis y metritis.

Info

Publication number
ES2095578T3
ES2095578T3 ES93305506T ES93305506T ES2095578T3 ES 2095578 T3 ES2095578 T3 ES 2095578T3 ES 93305506 T ES93305506 T ES 93305506T ES 93305506 T ES93305506 T ES 93305506T ES 2095578 T3 ES2095578 T3 ES 2095578T3
Authority
ES
Spain
Prior art keywords
metritis
composition
mastitis
treatment
acetoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93305506T
Other languages
English (en)
Inventor
A H J Rajamannan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2095578T3 publication Critical patent/ES2095578T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Disintegrating Or Milling (AREA)
  • Organic Insulating Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION QUE COMPRENDE DIACETILO Y ACETOINA PARA USO EN EL TRATAMIENTO DE MAMITIS Y METRITIS. PREFERENTEMENTE, LA COMPOSICIOM PUEDE USARSE PARA TRATAR MAMITIS Y METRITIS DEL GANADO BOVINO.
ES93305506T 1992-07-14 1993-07-14 Composicion para el tratamiento de mastitis y metritis. Expired - Lifetime ES2095578T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/913,034 US5260341A (en) 1992-07-14 1992-07-14 Product and process for treating bovine mastitis and bovine metritis

Publications (1)

Publication Number Publication Date
ES2095578T3 true ES2095578T3 (es) 1997-02-16

Family

ID=25432872

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93305506T Expired - Lifetime ES2095578T3 (es) 1992-07-14 1993-07-14 Composicion para el tratamiento de mastitis y metritis.

Country Status (13)

Country Link
US (1) US5260341A (es)
EP (1) EP0579488B1 (es)
JP (1) JPH06256176A (es)
AT (1) ATE143804T1 (es)
AU (1) AU676473B2 (es)
CA (1) CA2097740C (es)
DE (1) DE69305267T2 (es)
DK (1) DK0579488T3 (es)
ES (1) ES2095578T3 (es)
GR (1) GR3022030T3 (es)
MX (1) MX9304185A (es)
NZ (1) NZ248135A (es)
ZA (1) ZA934021B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449517A (en) * 1993-11-22 1995-09-12 Fitzjarrell; Edwin A. Method and formulation for eliminating fleas on animals
US5622123A (en) * 1995-08-10 1997-04-22 Aqua Heat Technology, Inc. Process and apparatus for killing soil pathogens
US5846543A (en) * 1995-10-24 1998-12-08 Hassler; Mark A. Bovine mastitis treatment
DE19631037C2 (de) * 1996-08-01 2002-12-05 Boehringer Ingelheim Vetmed Neue Wirkstoffkombinationen aus bacterizid wirkenden Substanzen mit terpenhaltigen Pflanzenextrakten
GT199800140A (es) * 1997-09-12 2000-02-29 Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimientos para fabricarla.
PL342648A1 (en) * 1998-02-02 2001-06-18 Boehringer Ingelheim Vetmed Veterinary application of a combination of active agent consisting of bactericides and terpene containing plant extracts
NL1014260C2 (nl) * 2000-02-02 2001-08-03 Lely Entpr Ag Inrichting voor het detecteren van fysische afwijkingen in melk.
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
RU2454972C2 (ru) * 2010-03-19 2012-07-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана" Способ лечения синдрома метрит-мастит-агалактия (мма) у свиноматок
CN104095900A (zh) * 2014-07-11 2014-10-15 上海育生堂科技有限公司 一种用于通乳的可清热解毒、排毒透脓的中药酒膏药
CN104721393A (zh) * 2015-03-24 2015-06-24 臧兰恕 一种治疗热毒炽盛型乳痈的中药组合物
RU2699723C1 (ru) * 2019-01-14 2019-09-09 Общество с ограниченной ответственностью "Агровейт" Препарат "райдо" для профилактики и лечения маститов у коров и способ его получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904780A (en) * 1973-05-30 1975-09-09 Suntory Ltd Method for giving and increasing the flavor resembling to dairy product
US4320149A (en) * 1979-10-15 1982-03-16 Minnesota Mining And Manufacturing Company Use of fluorinated beta-diketones as antiplaque agents
JPS5929618A (ja) * 1982-08-11 1984-02-16 T Hasegawa Co Ltd 虫歯防止剤
US5147652A (en) * 1990-07-03 1992-09-15 Cell Research Corporation Autobiotics and their use in eliminating nonself cells in vivo

Also Published As

Publication number Publication date
EP0579488B1 (en) 1996-10-09
DK0579488T3 (da) 1996-11-18
CA2097740A1 (en) 1994-01-15
NZ248135A (en) 1995-10-26
JPH06256176A (ja) 1994-09-13
DE69305267D1 (de) 1996-11-14
MX9304185A (es) 1994-04-29
ZA934021B (en) 1995-01-16
DE69305267T2 (de) 1997-03-13
ATE143804T1 (de) 1996-10-15
AU4148693A (en) 1994-01-20
GR3022030T3 (en) 1997-03-31
US5260341A (en) 1993-11-09
CA2097740C (en) 2002-03-26
EP0579488A1 (en) 1994-01-19
AU676473B2 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
ES2101578T3 (es) Agente analgesico y su utilizacion.
DE68919358T2 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
BR9403783A (pt) Uso de uma composição cosmética
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
GB2180152B (en) Anatomical dressings for cosmetic treatments
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
GR3031691T3 (en) Composition and method for preventing and treating inflammation with immunoglobulin a
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
GB8604528D0 (en) Therapeutic agents
OA09917A (en) Compounds for use in treating HIV infection
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
DE69304266T2 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
EP0607774A3 (es)
IT1267142B1 (it) Composto attivo complesso atto ad indurre un rafforzamento e rinnovamento della struttura elastica della cute.
UA885A1 (uk) Засiб для лiкуваhhя шлуhково-кишкових захворюваhь з озhаками дiареї
UA7413A1 (uk) Спосіб лікування псоріазу
EP0267402A3 (en) Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin
FI941707A (fi) Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579488

Country of ref document: ES